Tetragon Completes $50M Tender Offer Amid Deep Valuation Gap

LONDON, UK – April 14, 2026 – Tetragon Financial Group Limited has finalized its latest capital return initiative, completing a nearly $50 million tender offer for its non-voting shares. The move, which was significantly oversubscribed by investors, highlights the persistent tension between the investment firm's strong underlying asset performance and the deep discount at which its shares trade on the open market.

The Guernsey-based closed-ended investment company announced today it has accepted for purchase 3,773,581 non-voting shares at a price of $13.25 per share. The total cost of the repurchase amounts to $49,999,948.25, excluding fees. The offer, structured as a "modified Dutch auction," drew substantial interest from shareholders, with a total of 5,660,906 shares tendered at or below the final purchase price, forcing a proration.

A Familiar Capital Return Strategy

This tender offer is not an isolated event but rather the latest chapter in Tetragon's long-standing strategy of returning capital to its shareholders. The firm, whose shares are listed on Euronext in Amsterdam and the London Stock Exchange, has consistently employed a dual approach of quarterly dividends and share repurchases to manage its capital structure and signal value.

The recently concluded $50 million offer follows a pattern of similar actions, including a $25 million share repurchase program in March 2024 and a $50 million tender offer in November 2023. The company’s rationale, often repeated in investor communications, is that buying back its own stock at a price below its Net Asset Value (NAV) per share is "accretive" for the remaining shareholders. In simple terms, each share that remains outstanding represents a slightly larger piece of the company’s underlying asset pie, theoretically increasing its intrinsic value.

Alongside these buybacks, Tetragon maintains a policy of regular dividend payments, having recently declared a $0.12 per share dividend for the final quarter of 2025. This consistent stream of returns is designed to appeal to its target base of long-term institutional and professional investors. However, the heavy reliance on tender offers and buybacks points to a more complex challenge facing the company.

The Persistent Discount Dilemma

The central issue for Tetragon, and a source of ongoing debate among market observers, is the profound and stubborn discount of its share price to its NAV. At the end of 2025, the company reported a fully diluted NAV per share of an impressive $41.88, following a year that delivered a 19.6% total return on NAV. Yet, its share price languished at $17.35, representing a staggering discount of nearly 59%.

This valuation gap means the market values the company at less than half the stated worth of its diverse portfolio of alternative assets. Despite a history of deploying significant capital—reportedly over $860 million in historical buybacks—these efforts have had a limited effect on closing this chasm. According to one market analyst, this suggests that "structural factors and a complex investment portfolio may be weighing more heavily on investor perception than the company's capital return activities."

The completion of the tender offer at $13.25 per share—the lowest price within the offered range of $13.25 to $15.25—further underscores this dilemma. While the buyback is mathematically accretive to the NAV, the price accepted is a fraction of the reported NAV, highlighting the disparity between the company's internal valuation and the price at which a significant number of its investors are willing to sell.

Reading the Market Signals

The mechanics and outcome of the tender offer provide a clear window into current investor sentiment. The fact that the offer was oversubscribed indicates a strong appetite among shareholders to liquidate their positions, even at a price far below the reported NAV. Because more shares were tendered than the company intended to purchase, a proration factor of 66.66% was applied. This means that shareholders who offered their stock at the winning price of $13.25 will only have approximately two-thirds of their tendered shares purchased, with the remainder being returned.

The use of a "modified Dutch auction" is also revealing. This process allows shareholders to select the price at which they are willing to sell within a specified range. The company then determines the single lowest price—the "clearing price"—that allows it to fulfill its purchase target. That the clearing price settled at the very bottom of the range suggests a high volume of tenders at that level, reinforcing the notion that many investors were eager for a liquidity event.

This outcome presents a mixed signal. On one hand, the company successfully deployed capital to shrink its share count, which should provide some support for the stock. On the other, the strong desire to sell at a deep discount could be interpreted as a lack of confidence from a segment of its investor base in the potential for the valuation gap to narrow in the near future.

Beyond Buybacks: A Shifting Portfolio Strategy

While financial engineering through buybacks grabs headlines, Tetragon is simultaneously executing a broader strategic pivot within its investment portfolio. This move may be more critical to its long-term value creation. Recent company reports and presentations show a deliberate shift away from more commoditized assets like Collateralized Loan Obligations (CLOs) and bank loans, which have been reduced to a small fraction of the portfolio.

In their place, Tetragon is increasing its focus on higher-growth, specialized strategies, particularly through its Tetragon Partners platform, which takes GP stakes in asset management businesses. This segment, combined with its equity funds, now represents a significant portion of the company's NAV. This rebalancing is aimed at capturing value from less correlated, idiosyncratic investments that have the potential for higher returns.

The success of this underlying strategy was evident in its 2025 performance, where a robust 23.4% Return on Equity was driven by significant gains from key private equity holdings like Equitix and Ripple Labs. This demonstrates that the assets within the portfolio are performing well, even if that performance is not fully reflected in the public share price. By continuing to cultivate these unique investment streams while managing its balance sheet and returning capital, Tetragon is fighting a multi-front battle to convince the market of its true worth. The latest tender offer is just one tool in that ongoing campaign.

The company expects to promptly make payment for the accepted shares on or about April 17, 2026, and all shares tendered but not purchased will be returned to shareholders.